Press Releases

Danaher Corporation (NYSE: DHR) announced today that it will webcast its quarterly earnings conference call for the fourth quarter 2014 on Tuesday, January 27, 2015 beginning at 8:00 a.m. ET and...

Ahead of an institutional investor and analyst meeting to be held in New York, Danaher Corporation (NYSE:DHR) reaffirmed the Company's GAAP diluted net earnings per share guidance of $1.00 to...

Danaher Corporation (NYSE:DHR) announces that today it will settle the public tender offer for all the registered shares of Nobel Biocare Holding AG ("Nobel Biocare"). The additional acceptance...

Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.10 per share payable on January 30, 2015 to holders of record on...

Danaher Corporation (NYSE:DHR) will host a live video webcast of its Investor and Analyst Meeting on December 11, 2014 beginning at 12:30 p.m. ET and concluding at approximately 4:30 p.m. The...

Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, Thomas P. Joyce, Jr., will present at the Baird Industrial Conference in Chicago, Illinois today, Wednesday,...

WASHINGTON, D.C., November 7, 2014 -- Danaher Corporation (NYSE:DHR) will host a live video webcast of its Investor and Analyst Meeting on December 11, 2014 beginning at 1:00 p.m. ET and...

HemoCue America, a leader in advanced point-of-care testing (POCT) systems, today announced delivery of HemoCue(® )White Blood Cell (WBC) Analyzers to a number of US hospitals. The WBC Analyzers...

Danaher Corporation (NYSE:DHR) today announced results for the third quarter of 2014. Net earnings for the third quarter ended September 26, 2014 were $680.6 million, or $0.95 per share on a...

Danaher Corporation (NYSE: DHR) announced today a definitive agreement with NetScout Systems, Inc. ('NetScout") (NASDAQ: NTCT) to combine Danaher's Communications business with NetScout in a...

Washington, D.C., September 22, 2014 - Danaher Corporation (NYSE:DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2014 on Thursday, October...

Danaher Corporation (NYSE:DHR) has entered into a definitive transaction agreement with Nobel Biocare Holding AG ("Nobel Biocare") (SIX Swiss Exchange: NOBN) pursuant to which Danaher Corporation...

WASHINGTON, D.C., September 9, 2014 -- Danaher Corporation (NYSE:DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will present at the Morgan Stanley...

WASHINGTON, D.C., September 9, 2014 -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.10 per share payable on October...

Danaher Corporation (NYSE: DHR) today announced that the Company's Board of Directors has implemented its previously disclosed succession plan and will appoint Thomas P. Joyce, Jr. as President...

Danaher Corporation (NYSE: DHR) today announced results for the second quarter of 2014. Net earnings for the quarter ended June 27, 2014 were $676.4 million, or $0.95 per share on a diluted basis,...

Washington, D.C., June 26, 2014 - Danaher Corporation (NYSE:DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2014 on Thursday, July 17, 2014...

WASHINGTON, D.C., June 19, 2014 -- Danaher Corporation (NYSE:DHR) will host a live video webcast of its Investor and Analyst Meeting on June 24, 2014 beginning at 1:30 p.m. PT and concluding at...

Washington, D.C., June 4, 2014 - Danaher Corporation (NYSE:DHR) announced that Executive Vice President, Thomas P. Joyce, will present at the Goldman Sachs Global Healthcare Conference in Ranch...

WASHINGTON, D.C., May 13, 2014 - Danaher Corporation (NYSE: DHR) has been notified of an unsolicited "mini-tender offer" made by TRC Capital Corporation (TRC) to Danaher stockholders to purchase...

Washington, D.C., May 13, 2014 - Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, H. Lawrence Culp, Jr. will be presenting at the Electrical Products Group...

WASHINGTON, D.C., May 6, 2014 -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.10 per share payable on July 25, 2014 to...

Danaher Corporation (NYSE:DHR) today announced results for the first quarter of 2014. Net earnings for the quarter ended March 28, 2014 were $579.7 million, or $0.81 per share on a diluted basis,...

Danaher Corporation (NYSE: DHR) today announced that Executive Vice President Thomas P. Joyce, Jr. will succeed H. Lawrence Culp, Jr. as President and Chief Executive Officer upon Mr. Culp's...

Washington, D.C., April 4, 2014 - Danaher Corporation (NYSE:DHR) announced today that it has adjusted the start time for its first quarter 2014 earnings conference call on Thursday, April 17,...

Washington, D.C., March 31, 2014 - Danaher Corporation (NYSE:DHR) announced today several leadership appointments. Martin Gafinowitz has been promoted to Senior Vice President and Group Executive...

Washington, D.C., March 25, 2014 - Danaher Corporation (NYSE:DHR) announced today that it will webcast its quarterly earnings conference call for the first quarter 2014 on Thursday, April 17, 2014...

Washington, D.C., March 3, 2014 - Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, H. Lawrence Culp, Jr. will be presenting at the J.P. Morgan Aviation,...

WASHINGTON, D.C., February 18, 2014 -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.10 per share payable on April 25,...

Washington, D.C., February 12, 2014 - Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, H. Lawrence Culp, Jr. will be presenting at the Barclays Industrial...

Danaher Corporation (NYSE: DHR), the "Company", today announced results for the fourth quarter and full year 2013. All financial metrics in this release reflect only the Company's continuing...

Washington, D.C., January 14, 2014 - Danaher Corporation (NYSE:DHR) announced that its President and Chief Executive Officer, H. Lawrence Culp, Jr., will comment tomorrow on the Company's fourth...

Washington, D.C., January 8, 2014 - Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, H. Lawrence Culp, Jr. will be presenting at the J.P. Morgan Healthcare...

Washington, D.C., January 7, 2014 - Danaher Corporation (NYSE:DHR) announced today that it will webcast its quarterly earnings conference call for the fourth quarter 2013 on Tuesday, January 28,...

Ahead of an institutional investor and analyst meeting to be held in New York, Danaher Corporation (NYSE: DHR) reaffirmed the Company's adjusted diluted net earnings per share guidance of $0.91 to...

Washington, D.C., December 10, 2013 - Danaher Corporation (NYSE:DHR) will host a live video webcast of its Annual Investor and Analyst Meeting on December 12, 2013 beginning at 1:15 p.m. EST and...

WASHINGTON, D.C., December 10, 2013 -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.025 per share payable on January...

Washington, D.C., October 30, 2013 - Danaher Corporation (NYSE:DHR) announced that President and Chief Executive Officer, H. Lawrence Culp, Jr., will be presenting at the Robert W. Baird...

Danaher Corporation (NYSE: DHR) today announced results for the third quarter of 2013. All financial metrics in this release reflect only the Company's continuing operations and all references to...

Delivering the precision, clinical sensitivity and clinical specificity necessary to assist physicians with the diagnosis of myocardial infarction (MI), Beckman Coulter, Inc. announces the U.S....

Washington, D.C., September 17, 2013 - Danaher Corporation (NYSE:DHR) announced today that it will webcast its quarterly earnings conference call for the third quarter 2013 on Thursday, October...

WASHINGTON, D.C., September 10, 2013 -- Danaher Corporation (NYSE:DHR) announced today that its Board of Directors has approved a regular quarterly dividend of $0.025 per share payable on October...

Washington, D.C., September 9, 2013 - Danaher Corporation (NYSE:DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Morgan Stanley...

Danaher Corporation (NYSE: DHR) today announced results for the second quarter of 2013. All financial metrics in this release reflect only the Company's continuing operations unless otherwise...

WASHINGTON, D.C., July 9, 2013 - Danaher Corporation (NYSE:DHR) announced that it will comment today on the Company's second quarter 2013 financial performance in a presentation at its Investor...

WASHINGTON, D.C., July 2, 2013 -- Danaher Corporation (NYSE:DHR) will host a live video webcast of its Investor and Analyst Meeting on July 9, 2013 beginning at 1:00 p.m. CDT and concluding at...

Washington, D.C., June 18, 2013 - Danaher Corporation (NYSE:DHR) announced today that it will webcast its quarterly earnings conference call for the second quarter 2013 on Thursday, July 18, 2013...

Continuing its long history of proven clinical performance in diagnosis of myocardial infarction (MI), Beckman Coulter, Inc. announces the U.S. Food and Drug Administration (FDA) 510(k) clearance...

Washington, D.C., June 5, 2013 - Danaher Corporation (NYSE:DHR) announced that Executive Vice President and Chief Financial Officer, Daniel L. Comas, will be presenting at the Deutsche Bank Global...

Washington, D.C., May 28, 2012 - Danaher Corporation (NYSE:DHR) announced that Executive Vice President, Thomas P. Joyce, will be presenting at the Jefferies Global Healthcare Conference in New...